Clinical Trials Directory

Trials / Completed

CompletedNCT01596842

Effect of Omega-3 Fatty Acid on Vitamin D Activation

Effect of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Dong-A University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Extra-renal sources of 1, 25-dihydroxyvitamin D can be increased to normal serum 1, 25-dihydroxyvitamin D levels in chronic kidney disease patients after administration of high dose 25-hydroxyvitamin D. The investigators observed that 1, 25-dihydroxyvitamin D concentrations were significantly increased after 3 months of omega-3 FA supplementation compared to baseline levels without 25-hydroxyvitamin D administration in dialysis patients. In this study, the investigators hypothesized that omega-3 FA and 25-hydroxyvitamin D supplementations may increase 1, 25-dihydroxyvitamin D concentrations much more compared to 25-hydroxyvitamin D supplementation only in hemodialysis patients with insufficient or deficient 25-hydroxyvitamin D levels.

Conditions

Interventions

TypeNameDescription
DRUGOmega-3 fatty acid ethylester 90Omega-3 fatty acid ethylester 90, Dosage form :1g soft capsule, Dosage : one capsule, thrice a day, Duration : 12 weeks
OTHEROlive oilOlive oil, Dosage form :1g soft capsule, Dosage : one capsule, thrice a day, Duration : 12 weeks
OTHERcholecalciferolif baseline 25-hydroxyvitamin D levels are \< 15 ng/mL : 10,000IU/week, if baseline 25-hydroxyvitamin D levels are 16-30 ng/mL : 50,000IU/week, Duration : 12 weeks

Timeline

Start date
2012-05-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-05-11
Last updated
2015-03-10
Results posted
2015-03-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01596842. Inclusion in this directory is not an endorsement.